Vivo Bio Tech Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹13.51 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.05 per cent from ₹13.11 crore. This corresponds to a year-on-year *(YoY) growth of 10.65 per cent.
Operating Profit
Operating Profit stands at ₹5.49 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.48 per cent from ₹5.41 crore. This corresponds to a year-on-year *(YoY) decline of 0.90 per cent.
PBDT
PBDT stands at ₹4.23 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.68 per cent from ₹4.08 crore. This corresponds to a year-on-year *(YoY) growth of 14.02 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1.57 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.97 per cent from ₹1.51 crore. This corresponds to a year-on-year *(YoY) growth of 7.53 per cent.
Net Profit
Net Profit stands at ₹1.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 43.68 per cent from ₹0.87 crore. This represents a 52.44 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Vivo Bio Tech Ltd Earnings
- YOY
- QOQ
Vivo Bio Tech Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Vivo Bio Tech Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Vivo Bio Tech Ltd Financial Reports
Vivo Bio Tech Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Vivo Bio Tech | -0.85% | -2.94% | -6.11% | -4.19% | -12.70% | -29.16% |
| Source Natural | -2.79% | -7.38% | -21.02% | -24.35% | -23.52% | -39.42% |
| Samrat Pharma | -2.52% | -0.45% | -6.54% | 2.43% | -22.52% | -43.92% |
| Asston Pharmaceu | 0.03% | -0.45% | -6.83% | -11.38% | -13.49% | -41.84% |
| Kabra Drugs | -1.54% | -0.48% | -7.31% | -21.25% | -12.12% | 113.76% |
| Vivimed Labs. | -1.06% | -0.76% | -5.35% | -22.76% | -75.29% | -75.29% |
| Goldline Pharmaceutical | -4.99% | -4.99% | -4.99% | -4.99% | -4.99% | -4.99% |
Company Info
Company Information
E D & Wholetime Director : Kalyan Ram Mangipudi
Executive Director / Whole Time Director / CFO : K Sri Kalyan
E D & Wholetime Director : Alangudi Sankaranarayanan
Independent Non Exe. Director : Shyam Sunder Tipparaju
Non Executive Director : Karopadi Shivanand Nayak
Company Sec. & Compli. Officer : Vaishnvi Kiran Ayinampudi
Independent Non Exe. Director : Priya Rajender Goda
Non-Exec & Non-Independent Dir : Satyanarayan Vedula